These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE. Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164 [Abstract] [Full Text] [Related]
6. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ. J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [Abstract] [Full Text] [Related]
7. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin. Murthy V, Stemmer-Rachamimov AO, Haddad LA, Roy JE, Cutone AN, Beauchamp RL, Smith N, Louis DN, Ramesh V. Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618 [Abstract] [Full Text] [Related]
8. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. Aicher LD, Campbell JS, Yeung RS. J Biol Chem; 2001 Jun 15; 276(24):21017-21. PubMed ID: 11290735 [Abstract] [Full Text] [Related]
10. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. Hodges AK, Li S, Maynard J, Parry L, Braverman R, Cheadle JP, DeClue JE, Sampson JR. Hum Mol Genet; 2001 Dec 01; 10(25):2899-905. PubMed ID: 11741833 [Abstract] [Full Text] [Related]
11. Tuberous sclerosis: a syndrome of incomplete tumor suppression. McCall T, Chin SS, Salzman KL, Fults DW. Neurosurg Focus; 2006 Jan 15; 20(1):E3. PubMed ID: 16459993 [Abstract] [Full Text] [Related]
12. Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex. Chévere-Torres I, Kaphzan H, Bhattacharya A, Kang A, Maki JM, Gambello MJ, Arbiser JL, Santini E, Klann E. Neurobiol Dis; 2012 Mar 15; 45(3):1101-10. PubMed ID: 22198573 [Abstract] [Full Text] [Related]
13. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Ann Neurol; 1996 Dec 15; 40(6):941-4. PubMed ID: 9007104 [Abstract] [Full Text] [Related]
14. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas. Fackler I, DeClue JE, Rust H, Vu PA, Kutzner H, Rütten A, Kaddu S, Sander CA, Volkenandt M, Johnson MW, Vinters HV, Wienecke R. J Cutan Pathol; 2003 Mar 15; 30(3):174-7. PubMed ID: 12641776 [Abstract] [Full Text] [Related]
15. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P. Hum Mol Genet; 1998 Jun 15; 7(6):1053-7. PubMed ID: 9580671 [Abstract] [Full Text] [Related]
18. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J. Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13489-94. PubMed ID: 15342917 [Abstract] [Full Text] [Related]
19. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues. Gutmann DH, Zhang Y, Hasbani MJ, Goldberg MP, Plank TL, Petri Henske E. Acta Neuropathol; 2000 Mar 14; 99(3):223-30. PubMed ID: 10663963 [Abstract] [Full Text] [Related]